ICD-10 Code D75.822 | Immune-mediated heparin-induced thrombocytopenia Symptoms, Diagnosis, Billing

Immune-mediated heparin-induced thrombocytopenia (HIT) is a serious condition characterized by a decrease in platelet count due to an immune response triggered by heparin. This condition can lead to thrombotic complications, making accurate diagnosis and documentation essential. ICD-10 Code D75.822 facilitates precise coding for billing, clinical decision-making, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.

What is ICD-10 Code D75.822 for Immune-mediated heparin-induced thrombocytopenia?

ICD-10 Code D75.822 represents Immune-mediated heparin-induced thrombocytopenia, a condition where heparin administration leads to an immune response resulting in thrombocytopenia. This code should be used when documenting cases of HIT, particularly in patients who have received heparin and present with low platelet counts and potential thrombotic events.

ICD-10 Code D75.822 – Clinical Definition and Explanation of Immune-mediated heparin-induced thrombocytopenia

Immune-mediated heparin-induced thrombocytopenia occurs when antibodies form against complexes of heparin and platelet factor 4, leading to platelet activation and thrombosis. This condition can progress rapidly and requires immediate medical attention to prevent serious complications.

Key Clinical Features:

• Thrombocytopenia typically occurring 5-14 days after heparin exposure.
• Increased risk of venous and arterial thrombosis.
• Possible presentation of skin necrosis or limb ischemia.
• Laboratory confirmation through platelet factor 4 antibody testing.

ICD-10 Code D75.822 for Immune-mediated heparin-induced thrombocytopenia – SOAP Notes & Clinical Use

ICD-10 Code D75.822 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with immune-mediated heparin-induced thrombocytopenia. This code aids in capturing the severity of the condition and informs treatment strategies in both acute and chronic care settings.

What Does ICD-10 Code D75.822 for Immune-mediated heparin-induced thrombocytopenia Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D75.822 connects subjective patient reports and objective clinical findings to a formal diagnosis of immune-mediated heparin-induced thrombocytopenia. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code D75.822 – Immune-mediated heparin-induced thrombocytopenia

Immune-mediated heparin-induced thrombocytopenia requires prompt treatment to mitigate thrombotic risks. Hospitalization is often necessary for monitoring and management.

Antibiotic Therapy:

Supportive Care:

• Discontinue all heparin products immediately.
• Consider alternative anticoagulation therapy such as direct thrombin inhibitors.
• Monitor platelet counts and thrombotic events closely.

Infection Control:

How to Document Symptoms of Immune-mediated heparin-induced thrombocytopenia (ICD-10 D75.822) in SOAP Notes

Subjective:

• Patient reports recent heparin exposure for anticoagulation.
• Complaints of unusual bruising or bleeding.
• History of thrombosis or skin lesions post-heparin administration.

Objective:

• Platelet count significantly decreased (<150,000/µL).
• Signs of thrombosis on imaging studies.
• Positive platelet factor 4 antibody test.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Immune-mediated heparin-induced thrombocytopenia (ICD-10 Code D75.822)

Assessment:

• Diagnosis: Immune-mediated heparin-induced thrombocytopenia, moderate severity.
• ICD-10 Code: D75.822.
• Triggers: Recent heparin administration.

Plan:

• Immediate discontinuation of heparin.
• Initiate alternative anticoagulation therapy.
• Regular monitoring of platelet counts and thrombotic events.
• Patient education on signs of thrombosis and bleeding.

Treatment & Plan Section for ICD-10 Code D75.822 – Immune-mediated heparin-induced thrombocytopenia

• Use of direct thrombin inhibitors as alternative anticoagulants.
• Patient education on recognizing symptoms of thrombosis.
• Regular follow-up appointments to monitor platelet levels.
• Consider referral to a hematologist for complex cases.

Using ICD-10 Code D75.822 for Immune-mediated heparin-induced thrombocytopenia in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
• Use D75.822 for billing related to HIT management and treatment.
• Align treatment plans with clinical guidelines to support justified billing.
• Document any complications or comorbidities that may affect treatment.

Related ICD-10 Codes Often Used with Immune-mediated heparin-induced thrombocytopenia

• D75.821 – Heparin-induced thrombocytopenia, unspecified
• D69.6 – Thrombocytopenia, unspecified

ICD-10 Code D75.822 in Medical Billing and Insurance for Immune-mediated heparin-induced thrombocytopenia

ICD-10 Code D75.822 is critical for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings and patient history to support the use of D75.822.
• Ensure that the code is used in conjunction with appropriate CPT codes for services rendered.
• Include details of any complications or additional treatments in the medical record.

Common CPT Pairings: